|Articles|April 4, 2019

Greater simplicity and reliability in the determination of amino acid sequences

Shimadzu, a worldwide leading manufacturer of analytical instrumentation, provides perfect fit solutions in hardware and software components. For amino acid sequences, the PPSQ 51A / 53 A protein sequencer series and the LabSolutions PPSQ software create user benefits leading to greater simplicity and reliability combined with FDA compliance.

 

 

Shimadzu, a worldwide leading manufacturer of analytical instrumentation, provides perfect fit solutions in hardware and software components. For amino acid sequences, the PPSQ 51A / 53 A protein sequencer series and the LabSolutions PPSQ software create user benefits leading to greater simplicity and reliability combined with FDA compliance.

 

PPSQ protein sequencers separate PTH-amino acids isocratically. This improves baseline stability and allows high-sensitivity analysis of PTH-amino acids. Isocratic sequence analysis provides more stable retention times, so peaks detected in previous cycles can be cancelled using subtraction chromatogram processing, making it easier to identify sequences.

 

LabSolutions PPSQ software provides compliance with FDA 21 CFR Part 11 guidelines and enables compliance with the security, user management and audit trail requirements specified by FDA 21 CFR Part 11. Specialized protein sequencer software makes it simple to perform reprocessing of chromatograms, overlay of multiple chromatograms and automatic estimation of amino acid sequences, which are required for sequence analysis.

 

Contact Details:

Company Name: Shimadzu Europa GmbH
Website: www.shimadzu.eu
Email: shimadzu@shimadzu.eu


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.